The market value of pharmaceutical companies in 2021 will be reshuffled!

Medicine is a fast-changing industry.

Source: Zhongkang Industrial Capital Research Center, Flush

Before 2015, companies with traditional Chinese medicine as the core occupied the pharmaceutical market value list.

After 2015, the pharmaceutical list has undergone major changes.

In 2020, the market value of devices and services has skyrocketed.

Source: Zhongkang Industrial Capital Research Center, Flush

However, after 2021, new changes have taken place in the market value list of the pharmaceutical market.

Source: Zhongkang Industrial Capital Research Center, Flush

1.

1.

The company has established four core technology platforms based on adenovirus vector vaccine technology, protein structure design and recombination technology, combination technology, and preparation technology.

2.

Wantai Bio has a leading and complete HPV vaccine product line.

There are also heavy varieties of varicella-zoster virus vaccine and new rotavirus vaccine in the pipeline under research.

Two, medical beauty

After the medical reform, the right to speak in medical insurance has continued to increase, and policy-immunized industries and companies have gradually received capital recognition, and self-financed "medicine equipment" has gradually been tapped, marked by the listing of "Huaxi Bio" and "Amic", and the medical device sector In 2021, the medical beauty of the company has emerged in 2021, successfully entering the top 25 A-share and H-share markets by value

1.

Huaxi Biotechnology has been rooted in the research and development of sodium hyaluronate raw materials for more than 20 years, and has now become a global leader in hyaluronic acid raw materials and terminal products.
On the one hand, the company has extended to medical terminals, on the other hand, it has also extended to cosmetics and food applications.
It has formed a leading manufacturer with an integrated upstream and downstream industrial chain layout with hyaluronic acid as the core
.

2.
Amic

Amec is a representative enterprise of light medical beauty.
At present, its main product is sodium hyaluronate composite solution for injection.
It is the only type III medical device approved by NMPA to improve neck wrinkles by the company in 2017.
Under supervision, the uniqueness has strong bargaining power in the face of large and decentralized downstream institutions.

The company has a number of major research projects, such as skin filling needles and surgical anti-adhesion products, botox needles for removing dynamic wrinkles, and liraglutide injection products for chronic weight management.
fat soluble deoxycholic acid injection, implants line, topical anesthetic creams and the like
.

Talented people come out from generation to generation, and they have led the way for hundreds of years.
The pharmaceutical market value list has undergone radical changes in the past five or six years.
Under the background of the continuous deepening of medical reform, enterprises can only achieve better development by continuously deepening innovation
.